Skip to main content

May 2014 - FRMC

05/21/2014
Tampa—The National Survey on Drug Use and Health estimated that 2.1 million Americans ≥12 years of age had prescription pain reliever abuse or dependence in 2012. Prescription opioid abuse leads to significant economic and healthcare costs,...
Tampa—The National Survey on Drug Use and Health estimated that 2.1 million Americans ≥12 years of age had prescription pain reliever abuse or dependence in 2012. Prescription opioid abuse leads to significant economic and healthcare costs,...
Tampa—The National Survey on...
05/21/2014
First Report Managed Care
05/21/2014
Tampa—Diabetes is associated with a sizeable national economic burden. In 2012 dollars, the burden of diagnosed cases in the United States was estimated at $245 billion. Patients with type 2 diabetes mellitus (T2DM)—accounting for 90% to 95%...
Tampa—Diabetes is associated with a sizeable national economic burden. In 2012 dollars, the burden of diagnosed cases in the United States was estimated at $245 billion. Patients with type 2 diabetes mellitus (T2DM)—accounting for 90% to 95%...
Tampa—Diabetes is associated...
05/21/2014
First Report Managed Care
05/21/2014
Tampa—With the recent FDA approvals of new drugs to treat rheumatoid arthritis (RA) and updated guidelines, healthcare professionals have more information than ever about the disease. Still, speakers at a satellite symposium at the AMCP...
Tampa—With the recent FDA approvals of new drugs to treat rheumatoid arthritis (RA) and updated guidelines, healthcare professionals have more information than ever about the disease. Still, speakers at a satellite symposium at the AMCP...
Tampa—With the recent FDA...
05/21/2014
First Report Managed Care
05/21/2014
Tampa—Biomarkers have become an important part of individualized care and targeted therapies. Specifically for oncology, more targeted therapies are receiving FDA approval, with a focus on finding oncology biomarkers that will predict risk,...
Tampa—Biomarkers have become an important part of individualized care and targeted therapies. Specifically for oncology, more targeted therapies are receiving FDA approval, with a focus on finding oncology biomarkers that will predict risk,...
Tampa—Biomarkers have become an...
05/21/2014
First Report Managed Care
05/21/2014
Tampa—Biologics are regularly used to treat different forms of inflammatory bowel disease (IBD). The most common types of IBD are Crohn’s disease and ulcerative colitis. However, biologic therapies used for IBD cost an estimated $15,000 to...
Tampa—Biologics are regularly used to treat different forms of inflammatory bowel disease (IBD). The most common types of IBD are Crohn’s disease and ulcerative colitis. However, biologic therapies used for IBD cost an estimated $15,000 to...
Tampa—Biologics are regularly...
05/21/2014
First Report Managed Care
05/21/2014
Tampa—The specialty pharmacy market is going to see increased competition and a number of orphan drug and breakthrough therapy approvals in the near future, according to Aimee Tharaldson, PharmD, senior clinic consultant, emerging...
Tampa—The specialty pharmacy market is going to see increased competition and a number of orphan drug and breakthrough therapy approvals in the near future, according to Aimee Tharaldson, PharmD, senior clinic consultant, emerging...
Tampa—The specialty pharmacy...
05/21/2014
First Report Managed Care
05/21/2014
Tampa—To decrease costs and increase quality of care, the way healthcare providers exchange information and make treatment decisions, must be integrated and provide recommendations. According to Dr. Edward Li, PharmD, BCOP, associate...
Tampa—To decrease costs and increase quality of care, the way healthcare providers exchange information and make treatment decisions, must be integrated and provide recommendations. According to Dr. Edward Li, PharmD, BCOP, associate...
Tampa—To decrease costs and...
05/21/2014
First Report Managed Care

News

News
05/21/2014
Since 2010, the FDA has approved 3 oral drugs—fingolimod, teriflunomide, and dimethyl fumarate—to treat patients with multiple sclerosis (MS).
Since 2010, the FDA has approved 3 oral drugs—fingolimod, teriflunomide, and dimethyl fumarate—to treat patients with multiple sclerosis (MS).
Since 2010, the FDA has approved...
05/21/2014
First Report Managed Care

Department

News Connection
05/21/2014
Tampa—Despite the difficulties pharmaceutical manufacturers face in getting drugs approved, the FDA does not require them to submit outcomes data. During a session at the AMCP meeting, 2 speakers mentioned that information could be helpful in...
Tampa—Despite the difficulties pharmaceutical manufacturers face in getting drugs approved, the FDA does not require them to submit outcomes data. During a session at the AMCP meeting, 2 speakers mentioned that information could be helpful in...
Tampa—Despite the difficulties...
05/21/2014
First Report Managed Care
Conference Insider
05/21/2014
Tampa—Managing the movement of the estimated 47 million to 50 million uninsured Americans into new insurance venues was the topic of a roundtable discussion led by Joe deSimone, research director, Health Strategies Group, during a session at...
Tampa—Managing the movement of the estimated 47 million to 50 million uninsured Americans into new insurance venues was the topic of a roundtable discussion led by Joe deSimone, research director, Health Strategies Group, during a session at...
Tampa—Managing the movement of...
05/21/2014
First Report Managed Care